{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:48:47Z","timestamp":1774442927289,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018ZX10732202-002-009"],"award-info":[{"award-number":["2018ZX10732202-002-009"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bone.2023.116680","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T02:37:51Z","timestamp":1674527871000},"page":"116680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Legumain inhibitor prevents breast cancer bone metastasis by attenuating osteoclast differentiation and function"],"prefix":"10.1016","volume":"169","author":[{"given":"Junsong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Tai","family":"Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bone.2023.116680_bb0005","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/bph.14709","article-title":"Multiple actions of parathyroid hormone-related protein in breast cancer bone metastasis","volume":"178","author":"Martin","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bone.2023.116680_bb0010","article-title":"Osteocytes and bone metastasis","volume":"14","author":"Riquelme","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bone.2023.116680_bb0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-030-20301-6_7","article-title":"Bone metastasis of breast cancer","volume":"1152","author":"Tahara","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.bone.2023.116680_bb0020","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/ijms22020636","article-title":"Recent discoveries of macromolecule- and cell-based biomarkers and therapeutic implications in breast cancer","volume":"22","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.bone.2023.116680_bb0025","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bone.2023.116680_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12032-013-0621-9","article-title":"Effects of legumain as a potential prognostic factor on gastric cancers","volume":"30","author":"Li","year":"2013","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.bone.2023.116680_bb0035","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bone.2023.116680_bb0040","unstructured":"G. A. Landrum RDKit: Open-Source Cheminformatics Software, version 2021.03.1."},{"issue":"2","key":"10.1016\/j.bone.2023.116680_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10637-020-01011-3","article-title":"Esomeprazole inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis","volume":"39","author":"Zhao","year":"2021","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bone.2023.116680_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-9936-1_12","article-title":"Methods to determine the effects of MIF on in vitro osteoclastogenesis using murine bone marrow-derived cells and human peripheral blood mononuclear cells","volume":"2080","author":"Gu","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"25","key":"10.1016\/j.bone.2023.116680_bb0055","doi-asserted-by":"crossref","first-page":"21346","DOI":"10.1074\/jbc.M112.355834","article-title":"Identification of NOG as a specific breast cancer bone metastasis-supporting gene","volume":"287","author":"Tarragona","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bone.2023.116680_bb0060","first-page":"6876","article-title":"A murine model of experimental metastasis to bone and bone marrow","volume":"48","author":"Arguello","year":"1988","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bone.2023.116680_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/0300985815586223","article-title":"Animal models of bone metastasis","volume":"52","author":"Simmons","year":"2015","journal-title":"Vet. Pathol."},{"issue":"2","key":"10.1016\/j.bone.2023.116680_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006689719505","article-title":"A novel orthotopic model of breast cancer metastasis to bone","volume":"17","author":"Lelekakis","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.bone.2023.116680_bb0075","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone metastasis: mechanisms, therapies, and biomarkers","volume":"101","author":"Cl\u00e9zardin","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bone.2023.116680_bb0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bone.2016.03.004","article-title":"E-cadherin is important for cell differentiation during osteoclastogenesis","volume":"86","author":"Fiorino","year":"2016","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2023.116680_bb0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1101\/gad.1407406","article-title":"Distinct roles for cysteine cathepsin genes in multistage tumorigenesis","volume":"20","author":"Gocheva","year":"2006","journal-title":"Genes Dev."},{"issue":"23","key":"10.1016\/j.bone.2023.116680_bb0090","doi-asserted-by":"crossref","first-page":"34356","DOI":"10.18632\/oncotarget.8879","article-title":"Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition and analysis of their phosphorylation signaling pathways","volume":"7","author":"Cui","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bone.2023.116680_bb0095","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41379-018-0180-x","article-title":"Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ","volume":"32","author":"Toss","year":"2019","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.bone.2023.116680_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju012","article-title":"Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis","volume":"106","author":"Lin","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.bone.2023.116680_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7150\/ijbs.36467","article-title":"Legumain promotes gastric cancer progression through tumor-associated macrophages in vitro and in vivo","volume":"16","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.bone.2023.116680_bb0110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jnci\/djz155","article-title":"Role of asparagine endopeptidase in mediating wild-type p53 inactivation of glioblastoma","volume":"112","author":"Lin","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"issue":"31","key":"10.1016\/j.bone.2023.116680_bb0115","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2174\/1381612826666201125111625","article-title":"An overview of targeting legumain for inhibiting cancers","volume":"27","author":"Reddy","year":"2021","journal-title":"Curr. Pharm. Des."},{"issue":"17","key":"10.1016\/j.bone.2023.116680_bb0120","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1021\/acs.jmedchem.7b00228","article-title":"Blockade of asparagine endopeptidase inhibits cancer metastasis","volume":"60","author":"Qi","year":"2017","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bone.2023.116680_bb0125","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jbmr.3618","article-title":"Understanding the bone in cancer metastasis","volume":"33","author":"Fornetti","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2023.116680_bb0130","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/jor.22795","article-title":"CA-074Me compound inhibits osteoclastogenesis via suppression of the NFATc1 and c-FOS signaling pathways","volume":"33","author":"Patel","year":"2015","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.bone.2023.116680_bb0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/mp200434n","article-title":"Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug","volume":"9","author":"Liu","year":"2012","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.bone.2023.116680_bb0140","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2174\/1389450117666161216125344","article-title":"Targeting legumain as a novel therapeutic strategy in cancers","volume":"18","author":"Mai","year":"2017","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.bone.2023.116680_bb0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.breast.2011.12.012","article-title":"Epirubicin: is it like doxorubicin in breast cancer?A clinical review","volume":"21","author":"Khasraw","year":"2012","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.bone.2023.116680_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.bone.2023.116680_bb0155","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1096\/fj.12-211748","article-title":"Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling","volume":"27","author":"Str\u00e5lberg","year":"2013","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.bone.2023.116680_bb0160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00223-004-0043-y","article-title":"Different cysteine proteinases involved in bone resorption and osteoclast formation","volume":"76","author":"Brage","year":"2005","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.bone.2023.116680_bb0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bone.2003.11.018","article-title":"Osteoclastogenesis is decreased by cysteine proteinase inhibitors","volume":"34","author":"Brage","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116680_bb0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jbmr.2599","article-title":"Wnt signaling inhibits osteoclast differentiation by activating canonical and noncanonical cAMP\/PKA pathways","volume":"31","author":"Weivoda","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2023.116680_bb0175","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1111\/jcmm.15140","article-title":"E-cadherin deregulation in breast cancer","volume":"24","author":"Corso","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.bone.2023.116680_bb0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/bchm.2001.382.5.777","article-title":"Activation of progelatinase a by mammalian legumain, a recently discovered cysteine proteinase","volume":"382","author":"Chen","year":"2001","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.bone.2023.116680_bb0185","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41418-018-0147-y","article-title":"Enhanced PAPSS2\/VCAN sulfation axis is essential for snail-mediated breast cancer cell migration and metastasis","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bone.2023.116680_bb0190","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/cells10051153","article-title":"The mechanism of asparagine endopeptidase in the progression of malignant tumors: a review","volume":"10","author":"Zhang","year":"2021","journal-title":"Cells"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:45:13Z","timestamp":1762659913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328223000121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"alternative-id":["S8756328223000121"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116680","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Legumain inhibitor prevents breast cancer bone metastasis by attenuating osteoclast differentiation and function","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116680"}}